Study to Evaluate the Long-term Safety of Rusfertide (PTG-300) in Subjects With Polycythemia Vera
Trial details
- Registry ID
- NCT06033586
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study to Evaluate the Long-term Safety of Rusfertide (PTG-300) in Subjects With Polycythemia VeraNCT06033586 | PTGX | Phase 3 | Active not recruiting | 2026-04-01Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |